View Press Releases

RainDance Technologies Appoints John A. Luckey Vice President of Product Development

October 10, 2014

Biotechnology professional brings proven experience designing, developing and delivering products for life-science applications

BILLERICA, MA - Oct 10, 2014 - RainDance Technologies, Inc., a genomics tools company simplifying the analysis of complex genetic diseases, today announced the appointment of John Luckey, Ph.D., as its new Vice President of Product Development.

Dr. Luckey brings more than 20 years of experience leading teams tasked with developing biotechnology systems and technology platforms. During his career, he has held senior product and platform development positions in companies including Roche NimbleGen, where he directed research and development activities for improving and expanding the company’s core DNA microarray synthesis technology and related instrumentation. At Roche, he also liaised with 454 Life Sciences development teams and participated on the global team tasked with defining a strategy for applying NGS technology to high-value clinical diagnostics applications. Dr. Luckey also managed product development and engineering activities at MJ Research, contributing to the design and development of the Opticon product family and Opticon Monitor software. In 1994, he founded GeneSys Technologies and brought to market the BaseStation DNA Fragment Analyzer, an ultrathin gel electrophoresis system that he had designed, developed and patented. Dr. Luckey holds a Ph.D. in Analytical Chemistry and an M.B.A. in Executive Management from the University of Wisconsin, Madison.

“RainDance has developed a unique and powerful core droplet technology that has the potential to transform the industry because of its unmatched ability to provide accurate, early detection and detailed quantitative analysis of rare genetic abnormalities from complex samples,” said Dr. Luckey. “I am honored to join a talented team dedicated to making a profound difference in the understanding of the genetic basis of disease states.”

“John’s appointment further demonstrates RainDance’s commitment to recruiting and building a team passionate about developing and commercializing a new generation of genomic technologies. We are focused every day on delivering the products our customers and partners need to succeed in disease research,” said Roopom Banerjee, President and CEO of RainDance Technologies. “

Complex Genetics Made Simple
 RainDance Technologies offers an innovative product portfolio to research cell-free and cell-based biomarkers for hereditary risk predisposition, initial detection, pathology, and residual disease. The company’s products include:

• RainDrop® Digital PCR System: Ultra-sensitive digital PCR system for research of early detection and monitoring of biomarkers for cancers, viruses, pathogens, and immune disorders.
• ThunderBolts™ Cancer Panel: Next-Generation Sequencing (NGS) panel enabling highly sensitive, rapid, low input, and primary tumor profiling research in fresh biopsy, plasma and FFPE samples.
• ThunderStorm® NGS Content Enrichment System: High-throughput, fully automated NGS content enrichment solution enabling researchers to generate what we believe to be the best-in-class data on large-scale disease panels, while delivering affordable workflow for high-volume studies.

About RainDance Technologies
RainDance Technologies is making complex genetics simple. The company’s ultra-sensitive genomic tools enable research of novel non-invasive Fluid Biopsy™ applications that should result in more accurate, reliable, cost-effective, and early detection of cancer and inherited and infectious diseases. Major research institutions and laboratories around the world rely on the performance of RainDance systems. Based outside of Boston, Massachusetts, the company supports customers using RainDrop Digital PCR and ThunderStorm Next-Generation Sequencing Content Enrichment Systems through its international sales and service operations as well as a global network of distributors and commercial service providers.

The RainDance products are for Research Use Only. Not for use in diagnostic procedures.

RainDance Technologies, the RainDance Technologies logo, RainDrop, ThunderStorm, ThunderBolts, Fluid Biopsy, and RainStorm are trademarks of RainDance Technologies, Inc. All other brands may be trademarks of their respective holders.